Financial giants have made a conspicuous bullish move on Novo Nordisk. Our analysis of options history for Novo Nordisk (NYSE:NVO) revealed 22 unusual trades.
Delving into the details, we found 59% of traders were bullish, while 31% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $239,425, and 17 were calls, valued at $902,353.
Predicted Price Range
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $35.0 and $90.0 for Novo Nordisk, spanning the last three months.
Volume & Open Interest Trends
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Novo Nordisk's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Novo Nordisk's whale activity within a strike price range from $35.0 to $90.0 in the last 30 days.
Novo Nordisk 30-Day Option Volume & Interest Snapshot
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | CALL | TRADE | BULLISH | 01/15/27 | $29.0 | $25.5 | $28.4 | $35.00 | $88.0K | 6.2K | 31 |
| NVO | CALL | TRADE | BULLISH | 01/15/27 | $28.2 | $27.55 | $28.2 | $35.00 | $84.6K | 6.2K | 61 |
| NVO | CALL | TRADE | BEARISH | 01/21/28 | $8.7 | $8.0 | $8.06 | $90.00 | $80.6K | 4.4K | 100 |
| NVO | CALL | TRADE | BEARISH | 02/20/26 | $3.55 | $3.5 | $3.5 | $61.00 | $70.0K | 1.2K | 1.4K |
| NVO | PUT | TRADE | BEARISH | 03/20/26 | $3.75 | $3.7 | $3.75 | $60.00 | $68.6K | 7.5K | 193 |
About Novo Nordisk
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
After a thorough review of the options trading surrounding Novo Nordisk, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Present Market Standing of Novo Nordisk
- With a volume of 2,640,548, the price of NVO is down -2.77% at $61.15.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 7 days.
What The Experts Say On Novo Nordisk
1 market experts have recently issued ratings for this stock, with a consensus target price of $73.5.
- Reflecting concerns, an analyst from CICC lowers its rating to Outperform with a new price target of $73.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics.
- No comments yet. Be the first to comment!